C5 inhibition might have a potentially lower risk of endophthalmitis, preserving C3-associated effector functions, such as C3b-mediated opsonization and immune cell activation, compared to an upstream C3 blockade, which also abrogates C3b effects [14,38,58,59]. Here, C5 is linked to endophthalmitis.